InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: Samsa post# 23395

Wednesday, 02/08/2017 8:04:51 AM

Wednesday, February 08, 2017 8:04:51 AM

Post# of 38634
Thanks Samsa, perfectly catched.

Oxycodone looks no more an hot topic, patent secured is a non-event, Mallinkdroct deal ...just marginal, focalin residual doses...already expected.

I won't sell a single share, since I am one of the last "believer" in IPCI growth prospects.

But I respect everybody analysis and opinion, this is just my voice on the fact the IPCI looks like just not being in the biotech realm of investing.

biotech means risk; with risk comes reward or failure.

Many here are analysing IPCI looking for safe aspects, for reassuring elements, in a word...for certainty.

instead IPCI does belong to the opposite kind: risky, uncertain (even if somewhat limited). But you keep on reading of people waiting to buy or increase until major transaformation occurs. And maybe IPCI is not going to explode, never, but I just don't why someone invests into a biotech, expecting all those characteristics that usually you don't fine in ultra small cap biotechs.
I just don't get it.